Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06110065 · ClinicalTrials.gov registry record
CT-guided Pudendal Nerve Cryoneurolysis for Palliation of Malignancy-induced Pelvic Pain
A clinical trial, sponsored by University of Arizona.
- Not yet
- Registry status
- 15
- Enrollment target
NCT06110065 is a clinical trial that has not yet begun recruiting, run by University of Arizona. The registered enrollment target is 15 participants.
The verdict
NCT06110065 has not yet begun recruiting, sponsored by University of Arizona.
- NOT YET RECRUITING
- Registry status
- 15 participants
- Enrollment target
Study Summary
We want to study if a new treatment called "CT-guided bilateral pudendal nerve cryoneurolysis" can help people with severe and long-lasting pain in the pelvic area caused by cancer. We will closely follow and observe patients who undergo this treatment to see if it works well, what results it gives, and if there are any problems or side effects. "Percutaneous image-guided cryoneurolysis" involves using very cold temperatures to treat the nerves causing the pain. This method has been found to provide longer pain relief compared to injections or catheters, and it also has a lower risk of certain complications. We are conducting a study to assess the effectiveness of two different treatments for severe and persistent pelvic pain caused by cancer. The first treatment, known as "CT-guided bilateral pudendal nerve cryoneurolysis," involves using advanced imaging technology to precisely target and freeze the pudendal nerves, which are responsible for transmitting pain signals. By closely monitoring patients who receive this treatment, we aim to evaluate its efficacy, outcomes, and potential side effects. On the other hand, the second treatment approach, referred to as "Percutaneous image-guided cryoneurolysis," focuses on using extremely cold temperatures to alleviate pain originating from the pudendal nerves. This method has demonstrated extended pain relief compared to alternatives like injections or catheters. Additionally, it presents a lower risk of certain complications. Through our study, we seek to gain insights into the effectiveness and safety of both treatment methods, enhancing our understanding of how to address the challenging issue of cancer-related pelvic pain. The study will enroll patients who are dealing with severe and persistent pelvic pain from cancer. All patients will undergo the CT-guided bilateral pudendal nerve cryoneurolysis first type of treatment and if it is not effective in relieving the pain, they will be offered to undergo the second tr
Interventions
- DRUG CT-guided Pudendal Nerve Cryoneurolysis
- DRUG Percutaneous image-guided cryoneurolysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-11 |
| Est. Completion | 2027-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06110065
The ClinicalTrials.gov registry entry for NCT06110065 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CT-guided Pudendal Nerve Cryoneurolysis is the first listed.
NCT06110065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06110065 about?
NCT06110065 is a clinical study titled "CT-guided Pudendal Nerve Cryoneurolysis for Palliation of Malignancy-induced Pelvic Pain". We want to study if a new treatment called "CT-guided bilateral pudendal nerve cryoneurolysis" can help people with severe and long-lasting pain in the pelvic area caused by cancer. We will closely follow and observe patients who undergo this treatment to see if it works well, what results it gives,...
What is the current status of trial NCT06110065?
This trial is currently not yet recruiting. The enrollment target is 15 participants. The study started on 2023-11. Estimated completion is 2027-11.
What interventions are being tested in trial NCT06110065?
The interventions under investigation include: CT-guided Pudendal Nerve Cryoneurolysis (DRUG), Percutaneous image-guided cryoneurolysis (DRUG).
Who is sponsoring clinical trial NCT06110065?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.